Solveig Singleton

Patent Reform PotPourri

A few links to discussions of the current patent reform legislation:

From Matt Buchanan’s Promote the Progress; cheaper iPods, fewer cures?

Robert Armitage on how the courts have beaten Congress to the punch.

And a quote from Robert Cresanti, now with Ocean Tomo:

“[Ocean Tomo] will still proceed with the exchange (even if pending Congressional reforms pass), but many patents may be devalued.”, he warned. “Our hope is the Senate will come around to the same conclusion we have - that there is no pressing need for reform in light of what the courts and USPTO have done.”, he added.

October 29, 2007 | Comments |

Viewing 1 Comment

    • ^
    • v
    It is probably useful to remember that the pharmaceutical industry has its feet in both patent worlds - they patent inventions requiring high sunk costs and true innovation but they also patent things like the combining of new salts and compounds with known pill technology. They don't like the idea of obvious or inefficiency-creating patents disappearing because those represent a chunk of their "intellectual property", not the revolutionary cures.

Trackbacks

blog comments powered by Disqus